HAPIMMUNE Trademark

Trademark Overview

On Monday, January 11, 2021, a trademark application was filed for HAPIMMUNE with the United States Patent and Trademark Office. The USPTO has given the HAPIMMUNE trademark a serial number of 90981273. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2024. This trademark is owned by AETHON THERAPEUTICS, INC.. The HAPIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of pharmaceuticals
hapimmune

General Information

Serial Number90981273
Word MarkHAPIMMUNE
Filing DateMonday, January 11, 2021
Status700 - REGISTERED
Status DateTuesday, November 26, 2024
Registration Number7580394
Registration DateTuesday, November 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesScientific research in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 15, 2021
Primary Code042
First Use Anywhere DateThursday, April 4, 2024
First Use In Commerce DateThursday, April 4, 2024

Trademark Owner History

Party NameAETHON THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10169
Party NameAETHON THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10169
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNew York, NY 10016
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Thursday, January 14, 2021NEW APPLICATION ENTERED
Thursday, January 14, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 14, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, April 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 20, 2021ASSIGNED TO EXAMINER
Sunday, July 25, 2021LETTER OF SUSPENSION E-MAILED
Sunday, July 25, 2021SUSPENSION LETTER WRITTEN
Monday, December 27, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 30, 2021ASSIGNED TO LIE
Thursday, December 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, July 25, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 7, 2022SOU EXTENSION 1 GRANTED
Monday, November 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2023SOU EXTENSION 2 FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, June 21, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, July 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, July 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, July 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2023TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 25, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, July 25, 2023PETITION TO REVIVE-GRANTED
Wednesday, July 26, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, August 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2023SOU EXTENSION 3 GRANTED
Thursday, October 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 12, 2023SOU EXTENSION 3 FILED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 4 GRANTED
Monday, November 7, 2022SOU EXTENSION 1 FILED
Tuesday, August 22, 2023SOU EXTENSION 2 GRANTED
Friday, April 19, 2024SOU EXTENSION 4 FILED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, October 29, 2024USE AMENDMENT FILED
Tuesday, October 29, 2024SOU EXTENSION 5 FILED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, October 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, November 1, 2024DIVISIONAL PROCESSING COMPLETE
Friday, November 1, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 1, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, November 1, 2024SOU EXTENSION 5 GRANTED
Tuesday, November 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 26, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

hapimmune pharmaceuticals field research scientific